A historic shift in our drug policy has occurred, as the regulators permit the legalization of psilocybin fungi for therapeutic applications. Until now, these substances were severely restricted, but a increasing body of evidence suggests they may offer benefits for psychological conditions like anxiety. This change represents a substantial step to